Upcoming Allied Market Research
Ai In Pharma Market

AI in Pharma Market by Component Type (Software and Services), Technology Type (Machine Learning, Others Technologies), and Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction), and End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Research Centers and Academic & Government Institutes): Global Opportunity Analysis and Industry Forecast, 2021–2030

Pages: NA
Sep 2022 | 901 Views
Author(s) : Vineet Kumar
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Ai In Pharma Market

Request Now !

AI in Pharma Market Statistics: 2030

Artificial intelligence (AI) in pharma market consists of sales of AI in the pharma and related services that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be used to handle data and present results that encourage better decision-making and save human efforts, cost, and time. The market consists of revenue generated by AI companies, which are applied in the pharmaceutical industry.

Report Matric


 Market size available for the years


 Base year considered


 Forecast period


 Forecast unit

Value (USD)

 Segments covered

  • Component Type
  • Technology
  • Application
  • End User
  • Region

 Regions covered

  • North America (U.S. and Canada),
  • Europe (Germany, UK, France, and the Rest of Europe),
  • Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific).
  • LAMEA (Latin America, Middle East, and Africa)

 Companies covered


  • IBM Watson
  • Microsoft Corporation
  • Merck
  • GNS Healthcare
  • NVIDIA Corporation
  • XtalPi Inc.
  • Benevolent AI
  • Cloud Pharmaceuticals Inc.
  • Google
  • AstraZeneca
  • Atom wise Inc.
  • Exscientia
  • Cyclica
  • Others


COVID-19 scenario Analysis:

  • The emergence of COVID-19 pandemic has affected every industry except pharma industry across the world. Further, it is expected that growth of Pharma is mainly due to the companies resuming their operations and adapting to the new norm while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
  • The outbreak of COVID-19 pandemic has moderately inhibited the growth of pharma industries owing to financial impact, production and demand gap, or supply chain and market disruption.
  • In addition, the artificial intelligence for drug discovery (pharma) and healthcare market have grown significantly.
  • Furthermore, there are strong indications that the current pandemic has pushed the demand for technology and digital solutions. In the medium-to-long run the COVID-19 technology impact may be extremely positive. Everyone is forced to embrace new technologies and discover their benefits. Additional investments in digital infrastructure can be expected.

Top impacting factors: Market Scenario Analysis, Trends, Drivers, and Impact Analysis

The increase in number of cross-industry collaborations and partnerships, along with the rise in requirement to control drug discovery & development costs, are the two significant factors that are responsible for the growth of the global artificial intelligence in the drug discovery market. Moreover, the surge in adoption of cloud-based applications and services and the impending patent expiry of blockbuster drugs further drive the growth of the AI in pharma market.

Adoption of artificial intelligence (AI) in the drug discovery market

Artificial intelligence (AI) technology integration in the drug discovery is steadily increasing, and many pharmaceutical companies are highly focusing on drug development using artificial intelligence. The pharmaceutical companies are taking advantage of artificial intelligence technology to discover the drugs for the most complex diseases such as precision’s disease, Alzheimer’s disease, and pancreatic cancer. Artificial intelligence helps the pharmaceutical companies to streamline the research and development activities for the personalized medicines and the complex drug discovery.

Rise in demand to reduce drug discovery time

The drug discovery has become increasingly competitive and expensive, which has driven pharmaceutical companies to look into AI as a new method to reduce research and development costs, while avoiding costly errors. AI has a great potential to transform drug discovery by accelerating the research and development timeline, in an effort to make drugs affordable and improve the probability of FDA approval. This technology can also help with the repurposing new drugs, especially during the COVID-19 pandemic. AI and machine learning algorithms are able to identify molecules that may have failed in clinical trials and predict how the same compounds could be applied to target other diseases.

Key Segments covered:



 Component Type

  • Software
  • Services


  • Machine Learning,
  • Others Technologies


  • Diagnosis
  • Clinical Trial Research
  • Drug Discovery
  • Research and Development
  • Epidemic Prediction

 End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers and Academic & Government Institutes

Key benefits of the report:

  • This study presents the analytical depiction of the global AI in pharma market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of global AI in pharma market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the global AI in pharma market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the AI in pharma industry.
  • The report provides detailed global AI in pharma market analysis based on competitive intensity and how the competition will take shape in coming years.

Key Market Segments & Key Market Players

Segments Sub-segments
By Technology
  • Context-aware processing
  • Natural language processing
  • Querying method
  • Deep learning
  • Others

By Drug type
  • Small molecule
  • Large molecule

By Application
  • Clinical trial research
  • Drug discovery
  • Research and development
  • Others

By Region
  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Malaysia
    • Indonesia
    • Rest of Asia-Pacific
    • Latin America
    • Middle East
    • Africa

Key Market Players
  • Atlas Wearables
  • Biotronik
  • Cisco Systems
  • General Electronic company
  • Philips
  • Medtronic
  • IBM Corporation
  • Siemens
  • Hill-Rom
  • Johnson & Johnson.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Flash Sale

Start reading ,This Report and over 13000+ more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now









Purchase Full Report of
Ai In Pharma Market

Start reading.
This Report and over 13,000+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690  $3,321
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,930  $3,537
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,820  $4,947
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,540  $5,559
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,870  $7,896
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers